Timolol Maleate Solution
Product Images NDC 59651-313

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Timolol Maleate (NDC 59651-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Timolo Fig1)

Two line graphs from a U.S. study showing mean intraocular pressure (IOP) and standard deviation (mm Hg) over 24 weeks by treatment group. The top graph measures IOP at trough (hour 0) and the bottom at peak (hour 2) for Timolol Maleate Ophthalmic Gel Forming Solution 0.5% q.d. and Timolol Maleate Ophthalmic Solution 0.5% b.i.d.*

FDA Label Image

International Study (Timolo Fig2)

This image contains two line graphs from an international study comparing Timolol Maleate Ophthalmic Gel Forming Solution 0.5% and Timolol Maleate Ophthalmic Solution 0.5%. The graphs show intraocular pressure (mm Hg) over 24 weeks at two time points: Trough (Hour 0) and Peak (Hour 2). Each graph includes mean values with error bars for two dosing regimens, q.d. and b.i.d., with sample sizes of 226 and 116 respectively.*

FDA Label Image

Figure A (Timolo Fig3)

An instructional line drawing illustrating the administration of ophthalmic solution. The image shows a hand holding an eye drop bottle above an open eye, positioned to instill eye drops properly without touching the eye or eyelid. It visually guides users on how to apply the eye drops.*

FDA Label Image

Figure B (Timolo Fig4)

An instructional black and white line drawing depicts a person using their right hand to pull down the lower eyelid of their left eye, illustrating the technique for administering an ophthalmic solution.*

FDA Label Image

Figure C (Timolo Fig5)

An instructional illustration showing a person administering ophthalmic solution into the eye using a dropper bottle. The image depicts the hand holding the bottle above the eye to deliver drops.*

FDA Label Image

Package Label-principal Display Panel (0.5% Container Label)

Label for Timolol Maleate Ophthalmic Gel Forming Solution 0.5%, equivalent to 5 mg/mL timolol, 5 mL sterile ophthalmic solution. Manufactured by Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. Instructions note usual adult dosage, storage conditions, and caution to avoid freezing and protect from light.*

FDA Label Image

Package Label-principal Display Panel (0.5% – Container-Carton Label)

The packaging label for Timolol Maleate Ophthalmic Gel Forming Solution 0.5% (equivalent to Timolol Maleate 6.8 mg/mL or 5 mg/mL Timolol) in a 5 mL sterile solution. The label includes dosage form, strength, NDC 59651-313-05, manufacturer Aurobindo Pharma Limited, and directions for topical eye application. Additional details include storage instructions, distributor information (Aurobindo Pharma USA, Inc.), and inactive ingredients.*

FDA Label Image

Chemical Structure (Timolo Str)

Chemical structure of timolol maleate showing the molecular arrangement of its active ingredients, including the timolol moiety and maleate component as part of the ophthalmic solution formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.